Ramius Capital Nearly Doubles Activist Stake in Kensey Nash (KNSY)

In the original 13D filing, Ramius Capital disclosed a letter to the President and CEO expressing its belief that the Shares are significantly undervalued and highlighting several opportunities to improve the value of the shares, including refocusing efforts on its core biomaterials business and significantly reduce spending and management effort on the endovascular business. The firm also said the Board should consider a Dutch auction tender offer to repurchase up to 42% of its shares outstanding.
Ramius Capital made no amendments in the 'Purpose of Transaction' section of the filing.
Labels: Kensey Nash, KNSY, Ramius Capital
0 Comments:
Post a Comment
<< Home